|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | TMC278, a next-gener- ation nonnucleoside reverse transcriptase inhibitor(NNRTI), active against wild-type and NNRTI-resistant HIV-l显示文摘 | Azijn H Tirry I Vingerhoets J | 2010 | Antimicrob Agents Chemother2010，54，2： | 1 |
| 2 | TMC278 ,a nextgeneration nonnucleoside reverse transcriptase inhibitor (NNR- TI) ,active against wild-type and NNRTI-resistant HIV-1 显示文摘 | AZIJN H TIRRY I VINGERHOETS J | 2010 | Antimicrob Agents Chemother2010，54，2： | 1 |
| 3 | TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), ac- tive against wild-type and NNRTI-resistant HIV-1 显示文摘 | Azijn H Tiny I Vingerhoets J | 2010 | Antimicrob Agents Chemother2010，54，2： | 1 |
| 4 | TMC278, a next- generation nonnucleoside reverse transcriptase inhibitor (NNR- TI) , active against wild-type and NNRTI-resistant HIV-1 显示文摘 | AZIJN H TIRRY I VINGERHOETS J | 2010 | Antimicrob Agents Chemother2010，54，2： | 1 |
| 5 | TMC278, a next-generation nonnucleoside reverse transcrlptase inhibitor (NNRTI), active against wild-type and NNRTI resistant HIV1 显示文摘 | Azijn H Tirry I Vingerhoets J | 2010 | Antimicrob Agents Che mother2010，54，2： | 1 |
| 6 | TMC125,a novel nextgeneration nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1显示文摘 | Andries K Azijn H Thielemans T | 2004 | Antimicrob Agents Chemother2004，48，12： | 1 |
| 7 | TMC125 displays a high ge- netic barrier to the development of resistance: evidence from in vitro se- lection experiments显示文摘 | Vingerhoets J Azijn H Fransen E | 2005 | J Virol2005，79，12： | 1 |
| 8 | TMC278,a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI),active against wild-type and NNRTI-resistant HIV-1显示文摘 | Azijn H Tirry I Vingerhoets J | 2010 | Antimicrob Agents Chemother2010，54，2： | 1 |
| 9 | Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse tran- scriptase inhibitors显示文摘 | Tambuyzer L Azijn H Rimsky LT | 2009 | Antivir Ther2009，14，1： | 1 |
| 10 | TMC125, a novel next generation non-nueleoside reverse transcriptase inhibitor active against non-nueleoside reverse transcriptase inhibitor-resistant HIV-1 显示文摘 | Andries K Azijn H Thielemans T | 2004 | Antimicrob Agents Chemother2004，48，12： | 1 |
| 11 | TMC125 displays a high genetic harrier to the development of resistance : evidence from in-vitro selection experiments显示文摘 | Vingerhoets J Azijn H Fransen E | 2005 | J Virol2005，79，12： | 1 |
| 12 | Short communication: activity of etravirine on different HIV type 1 subtypes: in vitro suscep- tibility in treatmenVnaive patients and week 48 pooled DUET study da- ta显示文摘 | Vingerhoets J Azijn H Tambuyzer L | 2010 | AIDS Res Hum Retroviruses2010，26，6： | 1 |
| 13 | TMC278,a nextgeneration nonnucleoside reverse transcriptase inhibitor(NNRTI),active against wild-type and NNRTI-resistant HIV-1显示文摘 | Azijn H Tirry I Vingerhoets J | 2010 | Antimicrob Agents Chemother2010，54，2： | 1 |
| 14 | TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor- resistant human immunodeficiency virus type 1 显示文摘 | Andries K Azijn H Thielemans T | 2004 | Antimicrob Agents Chemother2004，48，： | 1 |
| 15 | TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1显示文摘 | Andries K Azijn H Thielemans T | 2004 | Antimicrob Agents Chemother2004，48，12： | 1 |
| 16 | TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates 显示文摘 | De Meyer S Azijn H Surleraux D | 2005 | Antimicrob Agents Chemother2005，49，： | 1 |
| 17 | TMC278, a next-genera- tion nonnucleoside reverse transcriptase inhibitor ( NNRTI ), ac- tive against wild-type and NNRTI-resistant HIV-1 显示文摘 | Azijn H Tirry I Vingerhoets J | 2010 | Antimicrob Agents Chemother2010，54，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员